HBO has renewed the Emmy®-winning half-hour drama series In Treatment, which will begin production on its third season in New York in early 2010, with debut scheduled for later in the year, it was announced today by Michael Lombardo, president, Programming Group and West Coast Operations, HBO.
In Treatment is synonymous with inspired writing and brilliant acting,” noted Lombardo. “This is the kind of show that could only flourish on HBO, and were proud to bring it back.”
Gabriel Byrne (Emmy® nominee and Golden Globe winner for Best Performance by an Actor in a Television Series Drama) stars in the series as Dr. Paul Weston, with additional cast members to be announced as they are confirmed.
The second season of In Treatment inspired resounding critical praise, with the New York Times hailing the show for “powerful acting and well-wrought dialogue,” while the Los Angeles Times said the “well-drawn and compelling performances are uniformly terrific.” The Chicago Sun-Times called the series “fascinating” and Newsday termed it a “fine and absorbing show.”
Joining the show as executive producers are Anya Epstein (HBOs “Tell Me You Love Me”) and Danny Futterman (“Capote”). Returning executive producers on the show include Stephen Levinson, Mark Wahlberg and Hagai Levi. It is expected that Paris Barclay will return as an executive producer/director.
In Treatment is produced by HBO Entertainment; executive producers, Stephen Levinson, Mark Wahlberg, Hagai Levi, Anya Epstein and Danny Futterman; co-executive producers, Noa Tishby and Gabriel Byrne; producer, Sarah Lum. In Treatment is produced by HBO Entertainment in association with Leverage, Closest to the Hole Productions and Sheleg.